119 related articles for article (PubMed ID: 38171885)
1. Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy.
Yue L; Gong T; Jiang W; Qian L; Gong W; Sun Y; Cai X; Xu H; Liu F; Wang H; Li S; Zhu Y; Zheng Z; Wu Q; Guo T
Proteomics; 2024 Mar; 24(6):e2300242. PubMed ID: 38171885
[TBL] [Abstract][Full Text] [Related]
2. The proteome of clear cell ovarian carcinoma.
Ji JX; Cochrane DR; Negri GL; Colborne S; Spencer Miko SE; Hoang LN; Farnell D; Tessier-Cloutier B; Huvila J; Thompson E; Leung S; Chiu D; Chow C; Ta M; Köbel M; Feil L; Anglesio M; Goode EL; Bolton K; Morin GB; Huntsman DG
J Pathol; 2022 Dec; 258(4):325-338. PubMed ID: 36031730
[TBL] [Abstract][Full Text] [Related]
3. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis-Associated Ovarian Cancer: Population Characteristics and Prognosis.
Barreta A; Sarian L; Ferracini AC; Eloy L; Brito ABC; de Angelo Andrade L; Derchain S
Int J Gynecol Cancer; 2018 Sep; 28(7):1251-1257. PubMed ID: 30142123
[TBL] [Abstract][Full Text] [Related]
5. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
Ceppi L; Grassi T; Galli F; Buda A; Aletti G; Lissoni AA; Adorni M; Garbi A; Colombo N; Bonazzi C; Landoni F; Fruscio R
Gynecol Oncol; 2021 Jan; 160(1):64-70. PubMed ID: 33077259
[TBL] [Abstract][Full Text] [Related]
6. Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics.
Kim YJ; Sweet SMM; Egertson JD; Sedgewick AJ; Woo S; Liao WL; Merrihew GE; Searle BC; Vaske C; Heaton R; MacCoss MJ; Hembrough T
J Proteome Res; 2019 Jan; 18(1):426-435. PubMed ID: 30481034
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue.
Zhou Q; Andersson R; Hu D; Bauden M; Kristl T; Sasor A; Pawłowski K; Pla I; Hilmersson KS; Zhou M; Lu F; Marko-Varga G; Ansari D
EBioMedicine; 2019 May; 43():282-294. PubMed ID: 30982764
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of transitional cell carcinoma-like variant of tubo-ovarian high-grade serous carcinoma.
Tessier-Cloutier B; Cochrane DR; Karnezis AN; Colborne S; Magrill J; Talhouk A; Zhang J; Leung S; Hughes CS; Piskorz A; Cheng AS; Greening K; du Bois A; Pfisterer J; Soslow RA; Kommoss S; Brenton JD; Morin GB; Gilks CB; Huntsman DG; Kommoss F
Hum Pathol; 2020 Jul; 101():40-52. PubMed ID: 32360491
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma.
Eltabbakh GH; Mount SL; Beatty B; Simmons-Arnold L; Cooper K
J Surg Oncol; 2006 Apr; 93(5):379-86. PubMed ID: 16550573
[TBL] [Abstract][Full Text] [Related]
10. High throughput and accurate serum proteome profiling by integrated sample preparation technology and single-run data independent mass spectrometry analysis.
Lin L; Zheng J; Yu Q; Chen W; Xing J; Chen C; Tian R
J Proteomics; 2018 Mar; 174():9-16. PubMed ID: 29278786
[TBL] [Abstract][Full Text] [Related]
11. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
12. Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma.
DeVorkin L; Hattersley M; Kim P; Ries J; Spowart J; Anglesio MS; Levi SM; Huntsman DG; Amaravadi RK; Winkler JD; Tinker AV; Lum JJ
Mol Cancer Res; 2017 Mar; 15(3):250-258. PubMed ID: 28184014
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of T cells, PD-L1 immune checkpoint and tumour associated macrophages in clear cell carcinoma of the ovary.
Sue-A-Quan R; Patel PG; Shakfa N; Nyi MN; Afriyie-Asante A; Kang EY; Köbel M; Koti M
Gynecol Oncol; 2021 Aug; 162(2):421-430. PubMed ID: 34088514
[TBL] [Abstract][Full Text] [Related]
14. Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
Ji JX; Cochrane DR; Tessier-Cloutier B; Chen SY; Ho G; Pathak KV; Alcazar IN; Farnell D; Leung S; Cheng A; Chow C; Colborne S; Negri GL; Kommoss F; Karnezis A; Morin GB; McAlpine JN; Gilks CB; Weissman BE; Trent JM; Hoang L; Pirrotte P; Wang Y; Huntsman DG
Clin Cancer Res; 2020 Aug; 26(16):4402-4413. PubMed ID: 32409304
[TBL] [Abstract][Full Text] [Related]
15. Resistance prediction in high-grade serous ovarian carcinoma with neoadjuvant chemotherapy using data-independent acquisition proteomics and an ovary-specific spectral library.
Qian L; Zhu J; Xue Z; Gong T; Xiang N; Yue L; Cai X; Gong W; Wang J; Sun R; Jiang W; Ge W; Wang H; Zheng Z; Wu Q; Zhu Y; Guo T
Mol Oncol; 2023 Aug; 17(8):1567-1580. PubMed ID: 36855266
[TBL] [Abstract][Full Text] [Related]
16. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis.
Sprung RW; Brock JW; Tanksley JP; Li M; Washington MK; Slebos RJ; Liebler DC
Mol Cell Proteomics; 2009 Aug; 8(8):1988-98. PubMed ID: 19467989
[TBL] [Abstract][Full Text] [Related]
17. Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors.
Ku X; Sun Q; Zhu L; Gu Z; Han Y; Xu N; Meng C; Yang X; Yan W; Fang W
Mol Oncol; 2020 Apr; 14(4):721-741. PubMed ID: 31967407
[TBL] [Abstract][Full Text] [Related]
18. High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.
Zhu Y; Weiss T; Zhang Q; Sun R; Wang B; Yi X; Wu Z; Gao H; Cai X; Ruan G; Zhu T; Xu C; Lou S; Yu X; Gillet L; Blattmann P; Saba K; Fankhauser CD; Schmid MB; Rutishauser D; Ljubicic J; Christiansen A; Fritz C; Rupp NJ; Poyet C; Rushing E; Weller M; Roth P; Haralambieva E; Hofer S; Chen C; Jochum W; Gao X; Teng X; Chen L; Zhong Q; Wild PJ; Aebersold R; Guo T
Mol Oncol; 2019 Nov; 13(11):2305-2328. PubMed ID: 31495056
[TBL] [Abstract][Full Text] [Related]
19. SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary.
Jiang T; Diao X; Ding M; Niu X; Wang C; Qi Y; Jia W; Pang L; Hu W; Zou H; Li F
J Mol Histol; 2021 Jun; 52(3):539-544. PubMed ID: 33608777
[TBL] [Abstract][Full Text] [Related]
20. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
